If you’ve followed my work, you know I’m passionate about pairing evidence with everyday habits so women can optimize fertility naturally. That’s why the new collaboration between Progyny and ŌURA caught my eye. As an OURA ring wearer myself, I believe it’s a forward-leaning step toward bringing continuous, personalized biometrics into real care conversations—from preconception to menopause. [1]
Progyny is the leading women’s health and family-building benefits company in the U.S. Rather than being a clinic or device maker, Progyny partners with employers and health plans to cover comprehensive, inclusive care—preconception, fertility treatment, adoption and surrogacy, pregnancy/postpartum, and midlife/menopause. Today, 530+ employers use Progyny’s solution, reaching 6.7 million+ people, and members access a curated national network of 1,000+ providers across 650 locations—with concierge support that helps patients navigate each decision point. [2]
In short: Progyny connects women (and their families) to the right care, at the right time, with benefits designed to improve outcomes and reduce friction. [2]
ŌURA’s smart ring continuously measures sleep quality, nightly skin temperature, heart rate and variability, respiratory rate, and activity—surfacing these signals in the Oura app as daily Readiness, Sleep, and Activity insights, plus Cycle Insights for menstrual and fertility awareness. For reproductive health, that continuous temperature and autonomic data are especially valuable because ovulation and cycle transitions are physiology events, not calendar events. [3]
Evidence is accumulating: a 2025 validation study reported that an Oura physiology-based algorithm detected 96.4% of ovulations with an average error of ±1.26 days, outperforming calendar-based estimates—including in users with irregular cycles. That level of precision can materially improve how we time conception attempts and how we interpret luteal-phase length and variability over time. [4]
According to the announcement, Progyny will incorporate Oura’s wearable data and insights into care-team decision support across the span of women’s health—preconception through menopause—with availability to Progyny clients (employers and health plans) beginning in early 2026. The goal is upstream engagement: spotting patterns sooner, personalizing recommendations, and supporting behavior change that moves the needle on outcomes. [1, 5]
1) Smarter timing without more stress.
Calendar apps assume a “typical” cycle; your body rarely does. When we align intercourse or insemination with physiology-detected ovulation—rather than predicted day-14—we reduce missed fertile windows and unnecessary anxiety. For patients planning natural conception or preparing for treatment, I’d review Oura cycle charts alongside symptoms and (when used) LH strips to refine timing in a data-informed, low-effort way. [3, 4]
2) Luteal-phase clues we can act on.
Short or inconsistent luteal phases may signal issues worth addressing (sleep debt, high allostatic load, thyroid concerns, under-recovery from training, etc.). Because ŌURA tracks sleep architecture, HRV, and temperature trends nightly, we can correlate cycle-phase shifts with routine habits—then target sleep hygiene, recovery, or nutrition changes that support progesterone and implantation biology. [3]
3) A continuous feedback loop for lifestyle tuning.
Fertility is exquisitely sensitive to sleep quality, stress physiology (HRV), and metabolic rhythm (temperature patterns). Having these signals pass into a benefits-supported care experience means your care team can reinforce the right lever at the right time—“this week, prioritize earlier wind-downs; next cycle, let’s nudge training intensity mid-luteal”—and then check whether your nightly data responds. That’s precision lifestyle medicine, not guesswork. [1, 3]
4) Beyond TTC: perimenopause and postpartum.
Cycle irregularity, sleep fragmentation, and autonomic shifts are hallmark features of perimenopause and the fourth trimester. Continuous temperature and HRV can help us recognize patterns (night-waking, hot-flash clusters, recovery debt) and personalize strategies—cooling routines, nutrition timing, or cognitive-behavioral sleep tactics—within a benefits framework that actually covers midlife care. [1, 2]
- It’s not a promise that every data point automatically becomes a medical order. Think of it as decision support: higher-quality context for clinicians and coaches to personalize care plans. Details on data sharing and workflows will continue to clarify as Progyny rolls out access in early 2026. [1, 5]
- It won’t replace diagnostic testing when we need it. Instead, it helps us decide smarter about which tests, when, and why—and it can shorten the time from “something feels off” to “here’s our plan.” [1]
- Track consistently for 2–3 cycles. Wear the ring nightly; resist micromanaging daily fluctuations. Meaning emerges in trends. [3]
- Annotate key moments. Log bleed days, LH surges (if you use them), notable stressors, illness, and travel. These anchors make the physiology easier to interpret in clinic. [3, 4]
- Bring the data to your visit. We’ll look at cycle-phase temperature curves, HRV recovery, and sleep efficiency to decide the next best lever—timing, labs, nutrition, or a targeted recovery plan. That’s how we blend natural optimization with evidence.
- Progyny × ŌURA partnership announcement. “Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause.” GlobeNewswire, July 10, 2025. GlobeNewswire
- Progyny scope & reach. “Employer FAQ.” Progyny, accessed Aug 3, 2025 (notes 530+ employers; 6.7M covered lives; 1,000+ providers in 650 locations; full-lifecycle women’s health benefits). Progyny
- Oura Cycle Insights feature. “Cycle Insights.” Oura Help Center (how the app uses nightly temperature trends, HRV and other signals; fertile-window and ovulation-confirmation details). support.ouraring.com
- Validation study. Thigpen N, Patel S, Zhang X. “Oura Ring as a Tool for Ovulation Detection: Validation Analysis.” Journal of Medical Internet Research 2025;27:e60667. (Detected 96.4% of ovulations; mean absolute error 1.26 days vs calendar method 3.44 days). JMIR
- Timing & availability detail. “Progyny Partners with ŌURA…” Women of Wearables, July 23, 2025 (notes availability to Progyny clients beginning early 2026). WOMEN OF WEARABLES
Dr Marina OBGYN